Association of thymidylate synthase gene polymorphism with its mRNA and protein expression and with prognosis in gastric cancer

被引:0
|
作者
Ishida, Y [1 ]
Kawakami, K [1 ]
Tanaka, Y [1 ]
Kanehira, E [1 ]
Omura, K [1 ]
Watanabe, G [1 ]
机构
[1] Kanazawa Univ, Sch Med, Dept Surg, Kanazawa, Ishikawa 9208641, Japan
关键词
TS polymorphism; 5-fluorouracil; gastric cancer; pharmacogenomics;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Thymidylate synthase (TS) is a target enzyme of 5-fluorouracil (5-FU). TS has a polymorphic repeated sequence in the 5'-UTR and the polymorphism is associated with TS protein expression. TS polymorphism has been reported to link with the efficacy of 5-FU-based chemotherapy in colorectal cancer. In this study, we examined whether the association among TS polymorphism, TS mRNA expression and TS protein expression is also observed in gastric cancer tissues and whether the TS polymorphism is a prognostic factor for patients with gastric cancer. We quantified TS mRNA isolated from 115 gastric cancer tissues by real-time reverse transcription PCR and TS protein in 72 available samples by the fluoro-dUMP binding assay. These values were compared with TS genotypes of the samples determined by a PCR assay. The tumor with the 3R/3R genotype had higher TS protein expression than that with the 2R/3R genotype, although there is no association between the TS genotype and mRNA expression. The result suggests that mRNA translation is responsible for the genotype-dependent difference of TS protein expression, as is consistent with our previous observation in colorectal cancer. This association encouraged us to further examine the link of the TS genotype with the stage of disease and the Prognosis of the patients. The clinicopathological analysis showed that gastric cancers with the 3R/3R genotype are at a more advanced stage than those with the combined 2R/2R and 2R/3R genotype. We observed a longer survival in those patients with the combined 2R/2R and 2R/3R genotype, compared with the 3R/3R genotype, although it did not reach significance when the patients who had received the oral fluoropyrimidines therapy were analyzed. These results warrant further large-scale clinical study of the role of the TS genotyping for the prediction of efficacy using 5-FU-based chemotherapy and prognosis in gastric cancer.
引用
收藏
页码:2805 / 2809
页数:5
相关论文
共 50 条
  • [1] Polymorphism of thymidylate synthase gene associated with its protein expression in human colon cancer
    Yu, Kai-Huan
    Wang, Wei-Xing
    Ding, You-Ming
    Li, Hui
    Wang, Ze-Sheng
    WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (04) : 617 - 621
  • [3] Gastric Cancer Susceptibility according to Methylenetetrahydrofolate Reductase and Thymidylate Synthase Gene Polymorphism
    Jung, Hun
    Lee, Jae Im
    Lee, Han Heong
    Kim, Soo Hong
    Hur, Hoon
    Jeon, Hae Myung
    JOURNAL OF THE KOREAN SURGICAL SOCIETY, 2010, 79 (01): : 27 - 34
  • [4] Associations between polymorphisms in the thymidylate synthase gene, the expression of thymidylate synthase mRNA and the microsatellite instability phenotype of colorectal cancer
    Merkelbach-Bruse, S
    Hans, V
    Mathiak, M
    Sanguedolce, R
    Alessandro, R
    Rüschoff, J
    Büttner, R
    Houshdaran, F
    Gullotti, L
    ONCOLOGY REPORTS, 2004, 11 (04) : 839 - 843
  • [5] Association between functional polymorphism of PD-L1 with its protein expression and prognosis of gastric cancer
    Wu, Yanhua
    Zhao, Tiancheng
    Jia, Zhifang
    Cao, Donghui
    Cao, Xueyuan
    Pan, Yuchen
    Zhao, Dan
    Zhang, Bin
    Jiang, Jing
    CANCER SCIENCE, 2018, 109 : 1437 - 1437
  • [6] Thymidylate synthase and dihydropyrimidine dehydrogenase gene expression in relation to differentiation of gastric cancer
    Ichikawa, W
    Takahashi, T
    Suto, K
    Nihei, Z
    Shirota, Y
    Shimizu, M
    Sasaki, Y
    Hirayama, R
    INTERNATIONAL JOURNAL OF CANCER, 2004, 112 (06) : 967 - 973
  • [7] Polymorphism of the programmed death-ligand 1 gene is associated with its protein expression and prognosis in gastric cancer
    Wu, Yanhua
    Zhao, Tiancheng
    Jia, Zhifang
    Cao, Donghui
    Cao, Xueyuan
    Pan, Yuchen
    Zhao, Dan
    Zhang, Bin
    Jiang, Jing
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 (07) : 1201 - 1207
  • [8] Association of thymidylate synthase polymorphisms with gastric cancer susceptibility
    Graziano, F
    Kawakami, K
    Watanabe, G
    Ruzzo, A
    Humar, B
    Santini, D
    Catalano, V
    Ficarelli, R
    Merriman, T
    Panunzi, S
    Testa, E
    Cascinu, S
    Bearzi, I
    Tonini, G
    Magnani, M
    INTERNATIONAL JOURNAL OF CANCER, 2004, 112 (06) : 1010 - 1014
  • [9] Intratumoral heterogeneous expression of thymidylate synthase in gastric cancer
    Chung-Kang, Cheng
    Ohno, Masakazu
    Nishimura, Koji
    Kuroda, Yoshikazu
    HEPATO-GASTROENTEROLOGY, 2006, 53 (69) : 458 - 462
  • [10] Thymidylate synthase polymorphism and microsatellite instability: Association in colorectal cancer
    Calascibetta, A
    Rausa, L
    Gullotti, L
    Buettner, R
    Sanguedolce, R
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2004, 23 (8-9): : 1377 - 1379